The Group looks to selectively grow its property portfolio by funding and acquiring high quality developments, newly developed facilities and investing in already completed, let healthcare real estate.
Activity in 2022 |
- Selectively acquired four standing assets in the year investing £52.9 million all within the UK
- Portfolio stands at 513, including 20 in Ireland, following some strategic disposals during the year that generated profits of £2.9 million (13% above book cost)
- Total property return in the year of 2.8%, with income growth remaining strong at 5.0% offset by unfavourable movements in valuation as a result of the increased uncertainty and higher interest environment faced
|
|
Looking forward |
- Sector fundamentals of long leases and government backed income continue to drive demand in sector
- In the short term, we expect investment activity will continue to be muted and will only take place if accretive to earnings
- The Group has two developments in legal due diligence, one in Ireland for £13.1 million and one in the UK for £3.5 million
|
|
Content sourced from 2022 Annual Report.